Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

iDose® TR marks a significant breakthrough in the treatment of glaucoma, delivering a consistent and reliable option for managing intraocular pressure (IOP). In contrast to traditional eye drops that require daily administration, iDose® TR is a small, implantable device engineered to release a controlled medication delivery directly into the eye over an prolonged period. This innovative approach eliminates the need for frequent dosing, dramatically boosting patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is placed during a simple and low-risk procedure, focused on your comfort and ease. Once in place, it ensures a steady flow of treatment, keeping IOP levels consistent and safeguarding your eyesight. Patients who find challenges in the routine of applying eye drops daily can experience significant advantages from this cutting-edge treatment.

Visit for more info At Eye Center South